Obesity induces limited changes to systemic and local immune profiles in treatment-naive human clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

Obesity induces limited changes to systemic and local immune profiles in treatment-naive human clear cell renal cell carcinoma

Published:2020-05-29 Issue:5 Volume:15 Page:e0233795
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Gibson Justin T.^ORCID,Norris Katlyn E.,Wald Gal,Buchta Rosean Claire M.,Thomas Lewis J.,Boi Shannon K.,Bertrand Laura A.,Bing Megan,Gordetsky Jennifer B.^ORCID,Deshane Jessy,Li Peng,Brown James A.,Nepple Kenneth G.,Norian Lyse A.

Funder

National Institutes of Health

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference44 articles.

1. Cancer statistics, 2018;RL Siegel;CA Cancer J Clin,2018

2. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;B Escudier;Ann Oncol,2016

3. Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma;RJ Motzer;N Engl J Med,2015

4. Cancer immunotherapy using checkpoint blockade;A Ribas;Science,2018

5. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma;RJ Motzer;N Engl J Med,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD1/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives;Molecular Cancer;2024-07-16

2. Treatment strategies for clear cell renal cell carcinoma: Past, present and future;Frontiers in Oncology;2023-03-21

3. Re-Evaluating the Effects of Obesity on Cancer Immunotherapy Outcomes in Renal Cancer: What Do We Really Know?;Frontiers in Immunology;2021-08-05

4. Identification of a Prognostic Risk Signature of Kidney Renal Clear Cell Carcinoma Based on Regulating the Immune Response Pathway Exploration;Journal of Oncology;2020-12-30